Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.
about
'Rescue' therapies for the management of Helicobacter pylori infection.Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.Second-line rescue therapy of helicobacter pylori infection.Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.Eradication of Helicobacter pylori: recent advances in treatment.Effectiveness of antiinfectives.Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.Helicobacter pylori infection: treatment options.Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.Effective regimens for the treatment of Helicobacter pylori infection.Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea."Rescue" regimens after Helicobacter pylori treatment failure.Eradication Rate of Helicobacter pylori using a Two-week Quadruple Therapy: A Report from Southern Iran.A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).Emerging therapies for the treatment of Helicobacter pylori infections.Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection.ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.Eradication of H. pylori Infection: the Challenge is on if Standard Therapy FailsFourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial.Rescue Therapy for Helicobacter pylori Infection 2012.Third-line rescue therapy for Helicobacter pylori infection.Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study.Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection?Levofloxacin-resistant Helicobacter pylori in Hong Kong.A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure.Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.UEG Week 2015 Poster Presentations
P2860
Q33371187-F832A73E-F557-4320-8D65-4A0293CAA578Q33452908-4EA05517-6FC2-4B20-889A-DBB75003CD51Q34409114-D1564937-9B03-4B21-8E52-DD892253F0C2Q34570815-D4411EF9-80D0-4B4F-B00C-C1F0966C00D2Q35692337-337741EF-944D-4227-BDC4-9FF9FB766E77Q36191284-A3D8C6CD-C89C-40D9-9BF8-18BF98155453Q36222718-D2339D14-E7AB-4C28-82AA-DBCAA3F5A0FFQ36322095-8BEFD9EE-1C12-42AD-A7FC-34B686ED717EQ36357419-0113EDB7-3027-4217-9935-9B91885C34BAQ36360546-22CA0F1D-3778-4862-85C7-8494B4EFC067Q36385174-D90768B6-E6F0-4B69-9A70-E570538BA1B3Q36404967-719CC445-0F67-499D-9836-639053A26827Q36423165-2E58A31A-98B0-45B9-B666-61AC32FC0E54Q36568724-C5931E51-F2A9-4834-B0DC-86ADA156FDFCQ37046537-4705F69D-3AC8-497D-8D14-447E4611B77AQ37273653-A54F2A0B-7D28-4E19-80BA-69D56C9E0F05Q37708347-BC92690E-EAE6-48EB-8684-4F21B607355DQ38093864-E5F86D44-9CD9-4E47-93BB-6E2434E9E728Q38424698-0063CB60-8AE4-4FF8-BDAF-4525DEAFF93BQ38882190-9DED1528-46CC-4036-BE3B-5EE8C94D5CD8Q40378087-7AAA89DA-F713-4561-9DCF-1430AD7E62DBQ40957363-19E5A024-8D68-4D89-9651-ED009CCB8909Q41172569-B4E63FBC-0BA4-4E65-9C8A-E1EFF900FE02Q41326393-49DF5D77-FB2D-4052-B786-C1DFDA6F1733Q42129420-EE9C642A-4056-4CCD-9F9F-080633773333Q42726333-8C63A81A-429E-4B12-A296-0A4ADB14D4DEQ43531758-7F298F16-E251-43C1-861B-3AD8CEEB4883Q44813868-5AD51C5F-2625-4436-A5E5-BFBE449CC3E8Q46049471-91FAE7A9-6054-4BEB-AF42-682A4541F643Q46383735-1FACE4A1-2300-481C-9507-901C289297D0Q46480398-9B37F81C-89E0-42D4-A8C0-1D308ACB1268Q46639990-C9185EB7-19C4-43A0-890D-6DFFF91323BCQ46752417-C05D221D-3D17-442E-9048-98CBB04E71B1Q46855381-7C84B78E-E3CF-4CB3-8455-B4493B5D9F88Q46879639-2AB96154-6160-46FF-96DB-6222E5639D61Q46901259-E5347D90-476D-4BEC-956B-9268DC98CDD4Q46922981-0A619EE0-CD5E-42BE-B74F-26BDB0B4A1CDQ46924788-6D2C18EA-6ACE-40BE-9E11-B96C211733EAQ51777109-7F9D15B5-A820-42D3-A470-DE017BF1D441Q56934656-316A7A50-5205-45F7-BBE4-032D01070240
P2860
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@en
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@nl
type
label
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@en
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@nl
prefLabel
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@en
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@nl
P2093
P2860
P1476
Levofloxacin-based triple ther ...... treatment: a randomized trial.
@en
P2093
Cammarota G
Candelli M
Cazzato IA
Cremonini F
Gabrielli M
Gasbarrini A
Gasbarrini G
P2860
P304
P356
10.1046/J.1365-2036.2003.01676.X
P407
P577
2003-09-01T00:00:00Z